These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35604182)

  • 21. A multidrug-resistant microorganism infection risk prediction model: development and validation in an emergency medicine population.
    González Del Castillo J; Julián-Jiménez A; Gamazo-Del Rio JJ; García-Lamberechts EJ; Llopis-Roca F; Guardiola Tey JM; Martínez-Ortiz de Zarate M; Navarro Bustos C; Piñera Salmerón P; Álvarez-Manzanares J; Ortega Romero MDM; Ruiz Grinspan M; García Gutiérrez S; Martín-Sánchez FJ; Candel González FJ;
    Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):309-323. PubMed ID: 31720894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2016 Jan; (1):CD009530. PubMed ID: 26797965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development, Validation, and Clinical Utility Assessment of a Prognostic Score for 1-Year Unplanned Rehospitalization or Death of Adult Sepsis Survivors.
    Shankar-Hari M; Rubenfeld GD; Ferrando-Vivas P; Harrison DA; Rowan K
    JAMA Netw Open; 2020 Sep; 3(9):e2013580. PubMed ID: 32926114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Machine Learning Approach for Mortality Prediction in COVID-19 Pneumonia: Development and Evaluation of the Piacenza Score.
    Halasz G; Sperti M; Villani M; Michelucci U; Agostoni P; Biagi A; Rossi L; Botti A; Mari C; Maccarini M; Pura F; Roveda L; Nardecchia A; Mottola E; Nolli M; Salvioni E; Mapelli M; Deriu MA; Piga D; Piepoli M
    J Med Internet Res; 2021 May; 23(5):e29058. PubMed ID: 33999838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative Respiratory Adverse Events in Pediatric Ambulatory Anesthesia: Development and Validation of a Risk Prediction Tool.
    Subramanyam R; Yeramaneni S; Hossain MM; Anneken AM; Varughese AM
    Anesth Analg; 2016 May; 122(5):1578-85. PubMed ID: 27101501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogen Distribution,Imaging Characteristics,and Establishment and Verification of Risk Prediction Model of Pulmonary Infection with Multi-drug Resistant Organism in Patients with Severe Craniocerebral Injury].
    Ye YQ; He LL; Liu GL; Zhang J; Long LS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):636-642. PubMed ID: 36065697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictive model for community acquired bacteremia in patients from an Internal Medicine Unit].
    Lizarralde Palacios E; Gutiérrez Macías A; Martínez Odriozola P; Franco Vicario R; García Jiménez N; Miguel de la Villa F
    Med Clin (Barc); 2004 Sep; 123(7):241-6. PubMed ID: 15482728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis.
    Torres A; Cillóniz C; Ferrer M; Gabarrús A; Polverino E; Villegas S; Marco F; Mensa J; Menéndez R; Niederman M
    Eur Respir J; 2015 May; 45(5):1353-63. PubMed ID: 25614173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttreatment variables improve outcome prediction after intra-arterial therapy for acute ischemic stroke.
    Prabhakaran S; Jovin TG; Tayal AH; Hussain MS; Nguyen TN; Sheth KN; Terry JB; Nogueira RG; Horev A; Gandhi D; Wisco D; Glenn BA; Ludwig B; Clemmons PF; Cronin CA; Tian M; Liebeskind D; Zaidat OO; Castonguay AC; Martin C; Mueller-Kronast N; English JD; Linfante I; Malisch TW; Gupta R
    Cerebrovasc Dis; 2014; 37(5):356-63. PubMed ID: 24942008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Smith S; Ratjen F; Remmington T; Waters V
    Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.
    Hu MY; Katchar K; Kyne L; Maroo S; Tummala S; Dreisbach V; Xu H; Leffler DA; Kelly CP
    Gastroenterology; 2009 Apr; 136(4):1206-14. PubMed ID: 19162027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factor Evaluation for Methicillin-Resistant
    Lewis PO
    Ann Pharmacother; 2021 Jan; 55(1):36-43. PubMed ID: 32545992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.
    Alene KA; Viney K; Gray DJ; McBryde ES; Xu Z; Clements ACA
    PLoS One; 2020; 15(1):e0227100. PubMed ID: 31899769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics.
    van Werkhoven CH; van der Tempel J; Jajou R; Thijsen SF; Diepersloot RJ; Bonten MJ; Postma DF; Oosterheert JJ
    Clin Microbiol Infect; 2015 Aug; 21(8):786.e1-8. PubMed ID: 25889357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.